Healthy Early Life Moments in Singapore
KK Women's and Children's Hospital
500 participants
Mar 18, 2022
INTERVENTIONAL
Conditions
Summary
This study aims to assess whether an integrated continuum of care from the preconception period, across maternity until the first 18 months of life, can promote maternal metabolic and mental health, as well as offspring health, among overweight and obese women.
Eligibility
Inclusion Criteria7
- Women aged 21-40 years
- BMI 25-40 kg/m2
- Intention to reside in Singapore for the next 4 years
- Chinese, Malay, Indian or any combination of these 3 ethnic groups
- Planning to conceive within 1 year
- Able to understand English
- Able to provide written, informed consent
Exclusion Criteria7
- Currently pregnant
- Known type 1 or type 2 diabetes
- On any anticonvulsant medication in the past 1 month
- On any oral steroid in the past 1 month (e.g. Prednisolone, Prednisone, Deltasone, Prelone, Methyl Prednisolone, Medrol, Hydrocortisone, Cortef, Dexamethasone, Decadron)
- On any oral, implanted contraception or intrauterine contraceptive device (IUCD) in situ in the past 1 month
- On any fertility medication (e.g. hormones injection, IVF treatments) other than Clomiphene/ Letrozole in the past 1 month
- On HIV or Hepatitis B or C medication in the past 1 month.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
The HELMS life-course Interventions, namely 4S ('Screening', 'Size', 'Supplementation' and 'Specific case management'), are developed to deliver care throughout the journey from preconception to postpartum periods. Screening involves health and risk assessments through physical and biomarker measurements, as well as emotion and sleep evaluations for mother, and developmental assessment for children. Body Size management encompasses education on weight status awareness and mother-child health implications, both mother-child weight tracking, healthy eating and physical activity guidance. Supplementation includes multi-micronutrient, vitamin D, calcium and/or Docosahexaenoic acid (DHA) supplements, which is phase-specific for mother, and vitamin D drops supplement for child. Specific case management comprises preconception sexual health and function management, pregnancy symptoms management, postpartum recovery management, infant growth monitoring and feeding management.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05207059